NVO · bullish
Called by Equity Mates Investing Podcast
on 2026-09-03 · horizon: medium term
“I wonder if there's, like, maybe a chance for Novo to get back in the game. But actually, the big news was Moderna...oral Ozempic is gonna hit the market pretty soon.”
No settled horizons yet — outcomes appear at 30/90/365 days.
General information only — a factual, backward-looking record of outcomes. NOT financial advice and NOT a recommendation to buy or sell anything. We report what happened after a source made a call; what you do with that is your decision. Hypothetical, paper-traded outcomes — entries are simulated at the first market bar after a call was detected; no real capital is at risk. Past performance is no guarantee of future results. Australia: this is general information only and does not take into account your objectives, financial situation or needs; consider its appropriateness and seek licensed advice before acting.